{"count": 4, "results": [{"_id": "38340381", "pmid": 38340381, "title": "Blockade of isoprenoids biosynthesis by simvastatin induces autophagy-mediated cell death via downstream c-Jun N-terminal kinase activation and cell cycle dysregulation in canine T-cell lymphoma cells.", "journal": "Res Vet Sci", "authors": ["Kobayashi K", "Baba K", "Kambayashi S", "Okuda M"], "date": "2024-03-01T00:00:00Z", "doi": "10.1016/j.rvsc.2024.105174", "meta_date_publication": "2024 Mar", "meta_volume": "169", "meta_issue": "", "meta_pages": "105174", "score": 50246.918, "text_hl": "This study aimed to elucidate the cytotoxic mechanisms of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_9615 @@@canine@@@ @<m>DISEASE_Lymphoma</m> @DISEASE_MESH:D008223 @@@lymphoma@@@ cells. ", "citations": {"NLM": "Kobayashi K, Baba K, Kambayashi S, Okuda M. Blockade of isoprenoids biosynthesis by simvastatin induces autophagy-mediated cell death via downstream c-Jun N-terminal kinase activation and cell cycle dysregulation in canine T-cell lymphoma cells. Res Vet Sci. 2024 Mar;169():105174. PMID: 38340381", "BibTeX": "@article{38340381, title={Blockade of isoprenoids biosynthesis by simvastatin induces autophagy-mediated cell death via downstream c-Jun N-terminal kinase activation and cell cycle dysregulation in canine T-cell lymphoma cells.}, author={Kobayashi K and Baba K and Kambayashi S and Okuda M}, journal={Res Vet Sci}, volume={169}, pages={105174}}"}}, {"_id": "15856040", "pmid": 15856040, "pmcid": "PMC2362042", "title": "HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphoma", "journal": "Br J Cancer", "authors": ["Cohen JI"], "date": "2005-05-09T00:00:00Z", "doi": "10.1038/sj.bjc.6602561", "meta_date_publication": "2005 May 9", "meta_volume": "92", "meta_issue": "9", "meta_pages": "1593-8", "score": 50071.79, "text_hl": "Statins may have a role in the treatment of @DISEASE_Epstein_Barr_Virus_Infections @DISEASE_MESH:D020031 @@@EBV@@@-driven @<m>DISEASE_Lymphoma</m> @DISEASE_MESH:D008223 @@@lymphomas@@@, most likely as part of combination therapy for these @<m>DISEASE_Lymphoma</m> @DISEASE_MESH:D008223 @@@lymphomas@@@.", "citations": {"NLM": "Cohen JI. HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphoma Br J Cancer. 2005 May 9;92(9):1593-8. PMID: 15856040", "BibTeX": "@article{15856040, title={HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphoma}, author={Cohen JI}, journal={Br J Cancer}, volume={92}, number={9}, pages={1593-8}}"}}, {"_id": "16585018", "pmid": 16585018, "title": "Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma.", "journal": "Haematologica", "authors": ["van der Spek E", "Bloem AC", "van de Donk NW", "Bogers LH", "van der Griend R", "Kramer MH", "de Weerdt O", "Wittebol S", "Lokhorst HM"], "date": "2006-04-01T00:00:00Z", "meta_date_publication": "2006 Apr", "meta_volume": "91", "meta_issue": "4", "meta_pages": "542-5", "score": 50056.535, "text_hl": "Dose-finding study of high-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ combined with standard chemotherapy in @SPECIES_9606 @@@patients@@@ with relapsed or refractory @DISEASE_Multiple_Myeloma @DISEASE_MESH:D009101 @@@myeloma or@@@ @<m>DISEASE_Lymphoma</m> @DISEASE_MESH:D008223 @@@lymphoma@@@.", "citations": {"NLM": "van der Spek E, Bloem AC, van de Donk NW, Bogers LH, van der Griend R, Kramer MH, de Weerdt O, Wittebol S, Lokhorst HM. Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma. Haematologica. 2006 Apr;91(4):542-5. PMID: 16585018", "BibTeX": "@article{16585018, title={Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma.}, author={van der Spek E and Bloem AC and van de Donk NW and Bogers LH and van der Griend R and Kramer MH and de Weerdt O and Wittebol S and Lokhorst HM}, journal={Haematologica}, volume={91}, number={4}, pages={542-5}}"}}, {"_id": "23449454", "pmid": 23449454, "pmcid": "PMC3734846", "title": "HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway", "journal": "Cell Death Dis", "authors": ["Qi XF", "Zheng L", "Lee KJ", "Kim DH", "Kim CS", "Cai DQ", "Wu Z", "Qin JW", "Yu YH", "Kim SK"], "date": "2013-02-28T00:00:00Z", "doi": "10.1038/cddis.2013.44", "meta_date_publication": "2013 Feb 28", "meta_volume": "4", "meta_issue": "2", "meta_pages": "e518", "score": 50041.414, "text_hl": "However, @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@fluvastatin@@@ showed higher @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@cytotoxicity@@@ towards @<m>DISEASE_Lymphoma</m> @DISEASE_MESH:D008223 @@@lymphoma@@@ cells than @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Qi XF, Zheng L, Lee KJ, Kim DH, Kim CS, Cai DQ, Wu Z, Qin JW, Yu YH, Kim SK. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway Cell Death Dis. 2013 Feb 28;4(2):e518. PMID: 23449454", "BibTeX": "@article{23449454, title={HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway}, author={Qi XF and Zheng L and Lee KJ and Kim DH and Kim CS and Cai DQ and Wu Z and Qin JW and Yu YH and Kim SK}, journal={Cell Death Dis}, volume={4}, number={2}, pages={e518}}"}}]}